Presentation
24 May 2022 Real-time optical diagnosis of prostate cancer: a clinical study on fresh biopsy cores
Author Affiliations +
Abstract
Prostate cancer is a significant healthcare problem in many western countries. In response to the current need for more accurate and less invasive real-time diagnosis systems, we are developing a thin optical probe that uses Raman spectroscopy to detect prostate cancer in vivo and in real-time. We present results from an ex vivo study on fresh biopsy cores seconds after collection. Findings show that our system can identify prostate cancer from benign tissue, as well as differentiate tissue with different Gleason patterns. We aim to apply this technique, in the near future, for real-time PCa identification during routine biopsy appointments.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Suse J. van Breugel, Liam Quinn, Hannah Holtkamp, Ariane Araquel-Laciamento, Satya Amirapu, Komal Srinivasa, Irene Low, Mary L. Christie, Michel K. Nieuwoudt, Morgan R. Pokorny, Ramya Nagarajan, M. Cather Simpson, Kamran Zargar-Shoshtari, and Claude Aguergaray "Real-time optical diagnosis of prostate cancer: a clinical study on fresh biopsy cores", Proc. SPIE 12146, Clinical Biophotonics II, 1214606 (24 May 2022); https://doi.org/10.1117/12.2621085
Advertisement
Advertisement
KEYWORDS
Biopsy

Tissues

Raman spectroscopy

Prostate cancer

Prostate

Principal component analysis

Tissue optics

Back to Top